TATVA CHINTAN PHARMA CHEM LTD.
Cah Flow
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|---|
Profit Before Tax | 447.79 | 1041.21 | 606.96 | 475.97 | 273.93 |
Adjustment | 207.09 | 116.31 | 68.47 | 85.59 | 75.72 |
Changes In working Capital | -284.15 | -771.15 | -380.40 | -226.44 | -216.59 |
Cash Flow after changes in Working Capital | 370.73 | 386.37 | 295.03 | 335.12 | 133.06 |
Cash Flow from Operating Activities | 277.83 | 202.30 | 196.94 | 253.12 | 73.56 |
Cash Flow from Investing Activities | -1011.43 | -1966.86 | -206.57 | -401.80 | -167.70 |
Cash Flow from Financing Activities | 377.95 | 2350.10 | -47.12 | 99.52 | 173.99 |
Net Cash Inflow / Outflow | -355.65 | 585.54 | -56.75 | -49.16 | 79.85 |
Opening Cash & Cash Equivalents | 630.17 | 44.81 | 101.56 | 157.45 | 77.60 |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | NA | NA | NA | NA | NA |
Cash & Cash Equivalent of Subsidiaries under liquidations | NA | NA | NA | NA | NA |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | NA | NA | NA | NA | NA |
Effect of Foreign Exchange Fluctuations | -0.86 | -0.18 | NA | NA | NA |
Closing Cash & Cash Equivalent | 273.66 | 630.17 | 44.81 | 108.29 | 157.45 |